Literature DB >> 12738989

Cell to cell contact required for bystander effect of the TNF-related apoptosis-inducing ligand (TRAIL) gene.

Xuefeng Huang1, Tongyu Lin, Jian Gu, Lidong Zhang, Jack A Roth, Jinsong Liu, Bingliang Fang.   

Abstract

We have previously reported that direct transfer of the TNF-related apoptosis-inducing ligand (TRAIL) gene resulted in an apoptotic bystander effect, and that this bystander effect was not transferable with cell culture media. To further characterize its mechanism we tested the bystander effect of TRAIL in the human ovarian cancer cell line DOV13, human lung cancer cell line A549, human hepatoma cell line Hepa G2, human breast cancer cell line MDA-MB231 and human colon cancer cell lines Lovo and DLD1. The bystander target cells were transduced with an adenovector expressing the lacZ gene (Ad/CMV-LacZ), while the effector cells were transduced with an adenovector expressing the green fluorescent protein (GFP)/TRAIL fusion gene. Effector and target cells were then cocultured in the same well with or without effector and target cell contact. In all the cell lines tested, target cells were killed if effector and target cell contact was permitted. However, no bystander effect occurred if effector and target cell contact was prevented. Furthermore, the bystander effect and apoptosis induction of TRAIL was dramatically reduced if cells were seeded at a very low density. Moreover, in all the cell lines tested, no detectable soluble TRAIL was found in media from the TRAIL-expressing cell cultures. Together, our results demonstrated that release of soluble TRAIL from transfer of the wild-type TRAIL gene is minimal, and that the bystander effect of the TRAIL gene is mainly mediated by membrane-bound TRAIL on the surface of transduced cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12738989

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  12 in total

1.  Enhanced effects of TRAIL-endostatin-based double-gene-radiotherapy on suppressing growth, promoting apoptosis and inducing cell cycle arrest in vascular endothelial cells.

Authors:  Yanbo Li; Caixia Guo; Zhicheng Wang; Pingsheng Gong; Zhiwei Sun; Shouliang Gong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-04-20

2.  microRNAome changes in bystander three-dimensional human tissue models suggest priming of apoptotic pathways.

Authors:  Olga Kovalchuk; Franz J Zemp; Jody N Filkowski; Alvin M Altamirano; Jennifer S Dickey; Gloria Jenkins-Baker; Stephen A Marino; David J Brenner; William M Bonner; Olga A Sedelnikova
Journal:  Carcinogenesis       Date:  2010-07-19       Impact factor: 4.944

3.  Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer.

Authors:  Xiaochun Zhang; Rex Min Cheung; Ritsuko Komaki; Bingliang Fang; Joe Y Chang
Journal:  Clin Cancer Res       Date:  2005-09-15       Impact factor: 12.531

4.  Eliminating established tumor in nu/nu nude mice by a tumor necrosis factor-alpha-related apoptosis-inducing ligand-armed oncolytic adenovirus.

Authors:  Fengqin Dong; Li Wang; John J Davis; Wenxian Hu; Lidong Zhang; Wei Guo; Fuminori Teraishi; Lin Ji; Bingliang Fang
Journal:  Clin Cancer Res       Date:  2006-09-01       Impact factor: 12.531

5.  TRAIL recombinant adenovirus triggers robust apoptosis in multidrug-resistant HL-60/Vinc cells preferentially through death receptor DR5.

Authors:  Ching-Huang Wu; Ching-Hai Kao; Ahmad R Safa
Journal:  Hum Gene Ther       Date:  2008-07       Impact factor: 5.695

6.  Live-cell imaging shows apoptosis initiates locally and propagates as a wave throughout syncytiotrophoblasts in primary cultures of human placental villous trophoblasts.

Authors:  M S Longtine; A Barton; B Chen; D M Nelson
Journal:  Placenta       Date:  2012-10-25       Impact factor: 3.481

7.  Exceptionally potent anti-tumor bystander activity of an scFv:sTRAIL fusion protein with specificity for EGP2 toward target antigen-negative tumor cells.

Authors:  Edwin Bremer; Douwe Samplonius; Bart-Jan Kroesen; Linda van Genne; Lou de Leij; Wijnand Helfrich
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

8.  Targeting different types of human meningioma and glioma cells using a novel adenoviral vector expressing GFP-TRAIL fusion protein from hTERT promoter.

Authors:  Jessica T Li; Ka Bian; Alan L Zhang; Dong H Kim; William W Ashley; Rahul Nath; Ian McCutcheon; Bingliang Fang; Ferid Murad
Journal:  Cancer Cell Int       Date:  2011-10-28       Impact factor: 5.722

9.  Gap junction communication dynamics and bystander effects from ultrasoft X-rays.

Authors:  G O Edwards; S W Botchway; G Hirst; C W Wharton; J K Chipman; R A Meldrum
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640

10.  Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model.

Authors:  Andrea Mohr; Mark Lyons; Laura Deedigan; Tina Harte; Georgina Shaw; Linda Howard; Frank Barry; Tim O'Brien; Ralf Zwacka
Journal:  J Cell Mol Med       Date:  2008-03-28       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.